Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: A prospective, observational study

13Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: The aim of our study was to assess the impact of plasma HIV-1 RNA level [viral load (VL)] variation and tenofovir exposure on kidney functions by analysing changes in calculated glomerular filtration rates (GFRs) over a 48 week period in patients with mild renal impairment. Patients and methods: A prospective observational study that included data from all consecutive HIV-infected patients who attended a metabolic clinic was conducted. Included were adult, antiretroviral (ARV)-experienced, tenofovir-naive patients, whose kidney functions were evaluated by calculated GFR using the simplified Modification of Diet in Renal Disease study equation (MDRD). Tenofovir-exposed patients were patients who initiated tenofovir therapy at baseline and tenofovir-unexposed patients were patients whose ARV therapy did not include tenofovir. Participants were stratified into three sub-groups according to the plasma HIV-1 RNA (VL) changes observed: sub-groups 1, 2 and 3 were patients with stable VL ≤50 copies/mL, >0.5 log10 VL increases and >0.5 VL log10 decreases, respectively. Results: Ninety-nine patients were enrolled and included in the analysis. Within the tenofovir-unexposed group, GFRs remained stable (ANOVA, P = 0.94) over the follow-up period. Within the tenofovir-exposed group, mean GFR changes varied significantly by sub-group (ANOVA, P < 0.01). In particular, GFR changes in sub-group 3 (+8.4 ± 12.4 mL/min) were different from those seen in sub-group 1 (-1.0 ± 8.8 mL/min) (P < 0.05) and sub-group 2 (-4.6 ± 8.8 mL/min) (P < 0.01). Conclusions: Observed improvements in GFR that occurred as a consequence of highly active ARV therapy-induced viral suppression may have more than offset any potential negative effects of tenofovir on renal function. © The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.

References Powered by Scopus

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: A 3-year randomized trial

1319Citations
N/AReaders
Get full text

Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

535Citations
N/AReaders
Get full text

Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study

361Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Systematic review and meta-analysis: Renal safety of tenofovir disoproxil fumarate in hiv-infected patients

458Citations
N/AReaders
Get full text

The nephrotoxic effects of HAART

118Citations
N/AReaders
Get full text

Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure

37Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Guaraldi, G., Roverato, A., Giovanardi, C., Ravera, F., Squillace, N., Orlando, G., … Palella, F. (2009). Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: A prospective, observational study. Journal of Antimicrobial Chemotherapy, 63(2), 374–379. https://doi.org/10.1093/jac/dkn499

Readers over time

‘11‘12‘15‘16‘17‘18‘20‘21‘2302468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

57%

Professor / Associate Prof. 3

21%

Researcher 3

21%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

60%

Agricultural and Biological Sciences 3

20%

Pharmacology, Toxicology and Pharmaceut... 2

13%

Psychology 1

7%

Save time finding and organizing research with Mendeley

Sign up for free
0